Clinical Trials Browser

Adenocarcinoma × rilotumumab × Gastrointestinal × Clear all

NCT01443065 2020-11-17

MEGA

Phase 2 Completed

Gastrointestinal

Adenocarcinoma, Esophageal Neoplasms, Stomach Neoplasms